Journal article
Thromboembolic Events in Users of Warfarin Treated with Different Skeletal Muscle Relaxants
Abstract
Background and Objectives: Warfarin and a skeletal muscle relaxant are co-treatments in nearly a quarter-million annual United States (US) office visits. Despite international calls to minimize patient harm arising from anticoagulant drug interactions, scant data exist on clinical outcomes in real-world populations. We examined effects of concomitant use of warfarin and individual muscle relaxants on rates of hospitalization for thromboembolism …
Authors
Leonard CE; Brensinger CM; Bilker WB; Soprano SE; Dhopeshwarkar N; Hecht TEH; Kasner SE; Nutescu EA; Holbrook A; Carr M
Journal
Medicina, Vol. 58, No. 9,
Publisher
MDPI
DOI
10.3390/medicina58091171
ISSN
1010-660X